XBIOTECH INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
XBIOTECH INC. (XBIT) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $229.00 thousand for the 12-month period ending 2018-12-31, per its 10-K/A filed 2019-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2019-03-15
- XBIOTECH INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-12-31 was -$131.00K.
- XBIOTECH INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-09-30 was $120.00K.
- XBIOTECH INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-06-30 was $28.00K.
- XBIOTECH INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-03-31 was $212.00K.
- XBIOTECH INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $229.00K.
- XBIOTECH INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was -$2.47M, a 219.55% decline from fiscal 2016.
- XBIOTECH INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was $2.07M.
- XBIOTECH INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was -$52.00K, a 104.21% decline from fiscal 2014.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$131.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | -$11.00K derived: sum of 2 quarters · filed 2019-03-15 | $17.00K derived: sum of 3 quarters · filed 2019-03-15 | $229.00K 10-K/A · filed 2019-03-15 |
| 2018-09-30 | $120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $148.00K derived: sum of 2 quarters · filed 2018-10-31 | $360.00K 10-Q · filed 2018-10-31 | $144.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2018-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $240.00K 10-Q · filed 2018-08-09 | $24.00K derived: sum of 3 quarters · filed 2019-03-15 | $24.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2018-03-31 | $212.00K 10-Q · filed 2018-05-08 | -$4.00K derived: sum of 2 quarters · filed 2019-03-15 | -$4.00K derived: sum of 3 quarters · filed 2019-03-15 | -$1.35M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-12-31 | -$216.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | -$216.00K derived: sum of 2 quarters · filed 2019-03-15 | -$1.56M derived: sum of 3 quarters · filed 2019-03-15 | -$2.47M 10-K/A · filed 2019-03-15 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$1.35M derived: sum of 2 quarters · filed 2018-10-31 | -$2.25M 10-Q · filed 2018-10-31 | -$898.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | -$1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$2.25M 10-Q · filed 2018-08-09 | -$898.00K derived: sum of 3 quarters · filed 2019-03-15 | -$604.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | -$905.00K 10-Q · filed 2018-05-08 | $451.00K derived: sum of 2 quarters · filed 2019-03-15 | $745.00K derived: sum of 3 quarters · filed 2019-03-15 | $911.00K derived: sum of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | $1.36M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15 | $1.65M derived: sum of 2 quarters · filed 2019-03-15 | $1.82M derived: sum of 3 quarters · filed 2019-03-15 | $2.07M 10-K/A · filed 2019-03-15 |
| 2016-09-30 | $294.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $460.00K derived: sum of 2 quarters · filed 2017-11-09 | $710.00K 10-Q · filed 2017-11-09 | $1.18M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $416.00K 10-Q · filed 2017-08-08 | $888.00K derived: sum of 3 quarters · filed 2018-03-16 | $1.30M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $250.00K 10-Q · filed 2017-05-10 | $722.00K derived: sum of 2 quarters · filed 2018-03-16 | $1.14M derived: sum of 3 quarters · filed 2018-03-16 | $805.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $885.00K derived: sum of 2 quarters · filed 2018-03-16 | $555.00K derived: sum of 3 quarters · filed 2018-03-16 | -$52.00K 10-K · filed 2018-03-16 |
| 2015-09-30 | $413.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $83.00K derived: sum of 2 quarters · filed 2016-11-14 | -$524.00K 10-Q · filed 2016-11-14 | -$216.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | -$330.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$937.00K 10-Q · filed 2016-08-12 | -$629.00K derived: sum of 3 quarters · filed 2017-03-16 | $180.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | -$607.00K 10-Q · filed 2016-05-13 | -$299.00K derived: sum of 2 quarters · filed 2017-03-16 | $510.00K derived: sum of 3 quarters · filed 2017-03-16 | $440.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $308.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.12M derived: sum of 2 quarters · filed 2017-03-16 | $1.05M derived: sum of 3 quarters · filed 2017-03-16 | $1.23M 10-K · filed 2017-03-16 |
| 2014-09-30 | $809.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $739.00K derived: sum of 2 quarters · filed 2015-11-13 | $926.00K 10-Q · filed 2015-11-13 | |
| 2014-06-30 | -$70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $117.00K 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | $187.00K 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | -$326.00K 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |